The study, "Breast Cancer Screening Using Tomosynthesis in Combination with Digital Mammography", was published in the June 25, 2014 issue of the Journal of the American Medical Association (:JAMA).

Hologic, Inc. HOLX recently attained the FDA approval for its 3DQuorum Imaging Technology, powered by Genius AI to be used in breast cancer screening. 3DQuorum technology works alongside Hologic’s ...

In 2009, Hologic revolutionized breast cancer screening with the introduction of the Genius™ 3D mammography™ exam, the only mammogram clinically proven and FDA approved as superior for all women, ...

BEDFORD, Mass., Sept. 8, 2014 /PRNewswire/ -- Hologic, Inc. today announced that its 3D mammography system (Hologic Selenia Dimensions 3D Breast Tomosynthesis) was named "Best in KLAS" in the digital ...

BEDFORD, Mass., Feb. 10, 2014 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) , a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and ...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) will showcase its expanding suite of breast and skeletal health products, including screening, interventional, ultrasound and surgical ...

Hologic Inc.’s (NASDAQ:HOLX) long wait to launch its 3D breast exam system is close to over. The company received an “approvable letter” from the Food & Drug Administration for its Selenia Dimensions ...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX), an innovative medical technology company primarily focused on improving women’s health, today announced a multi-year commitment to ...

Hologic, Inc. (Nasdaq: HOLX) announced today 3D ultrasound imaging is now available on the SuperSonic™ MACH™ 40 ultrasound system*. Clinicians can now access high-resolution B-mode and ShearWave™ PLUS ...

MARLBOROUGH, Mass., June 7, 2017 /PRNewswire/ -- Hologic, Inc. (Nasdaq: HOLX) announced today that the Genius™ 3D Mammography™ exam is now the only mammogram that is FDA-approved as superior to ...